Skip to main content
. 2018 Jun 29;9(50):29445–29452. doi: 10.18632/oncotarget.25655

Figure 1.

Figure 1

Representative examples of immunohistochemical staining intensities of MACROD2 expression, categories (A) ‘strong’, (B) ‘moderate’, (C) ‘weak’ and (D) ‘negative’, in stage II and III colon cancers.